AstraZeneca's cancer drug tops list of new brands launched in 2024
Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...
Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
IQVIA Holdings (IQV) Gets a Buy from RBC Capital
RBC Capital analyst Sean Dodge reiterated a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of $270.00. The ...
Lupin and Natco receives USFDA approval for Bosentan Tablets for Oral Suspension
Bosentan Tablets for Oral Suspension are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in pediatric patients aged 3 years and older with idiopathic or congenital ...
Pharmabiz13h
Lupin and Natco receive US FDA approval for generic Tracleer tablets for oral suspension
Lupin and Natco receive US FDA approval for generic Tracleer tablets for oral suspension: Our Bureau, Mumbai Monday, February 10, 2025, 15:45 Hrs [IST] Global pharma major Lupin L ...
Evercore ISI Sticks to Its Buy Rating for IQVIA Holdings (IQV)
Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on IQVIA Holdings (IQV – Research Report) on February 7 and set a price ...